Related Experiment Video
Updated: Aug 7, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular
Rafaela Soler1, Esther Rodríguez, Lorenzo Monserrat
1Department of Radiology, Complejo Hospitalario Universitario Juan Canalejo, La Coruña, Spain. rafaelasoler@telefonica.net
Insights
Delayed myocardial enhancement is common in hypertrophic cardiomyopathy (HCM), often linked to perfusion defects and reduced contractile function. These findings suggest potential roles in risk stratification for HCM patients.
Area of Science:
- Cardiovascular Imaging
- Cardiac MRI
- Cardiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in young adults.
- Cardiac MRI (CMR) is crucial for diagnosing and characterizing HCM.
- Understanding the relationship between different CMR findings is essential for patient management.
Purpose of the Study:
- To investigate the associations between myocardial delayed enhancement (MDE), first-pass perfusion (FPP), and contractile function in HCM patients.
- To determine the prevalence and distribution of MDE in HCM.
- To explore the clinical significance of these CMR parameters.
Main Methods:
- Prospective CMR examination of 53 HCM patients using a 1.5-T MR unit.
- Assessment of global left ventricular function, wall thickness, and mass.
- Myocardial tissue tagging for contractile function evaluation.
- T1-weighted sequences for FPP and MDE assessment.
Main Results:
- MDE was observed in 56.6% of patients, predominantly in hypertrophic segments, but also in normal-thickness segments.
- FPP defects at rest occurred in 30.1% of patients, correlating with reduced stroke volume and cardiac output.
- Hypokinetic segments were significantly thicker and associated with MDE.
Conclusions:
- MDE is prevalent in HCM, occurring in both hypertrophic and normal-thickness segments.
- Resting FPP defects and impaired contractile function are associated with MDE.
- Further research is needed to establish the role of MDE, FPP, and myocardial tagging in HCM risk stratification.
Purpose:
The aim of the study was to analyze the relationship between myocardial delayed enhancement, first-pass perfusion, and contractile function in hypertrophic cardiomyopathy (HCM) patients, using MR.
Methods:
Fifty-three patients diagnosed with HCM were prospectively examined using a 1.5-T MR unit. Multiphase gradient-echo sequences were performed to study global left ventricular function, wall thickness, and left ventricular mass. Myocardial tissue tagging was conducted to evaluate contractile function. T1-weighted inversion-recovery sequences were obtained at rest to study myocardial contrast enhancement at first pass and delayed enhancement 10 minutes later.
Results:
Delayed enhancement found in 30 patients (56.6%) was most commonly seen in hypertrophic segments. Nine patients exhibited delayed enhancement in segments with normal wall thickness (<15 mm). Sixteen patients (30.1%) showed first-pass perfusion defects at rest, which were associated with significantly lower stroke volume (P<0.05) and lower cardiac output (P<0.01). The hypokinetic segments found in 16 patients (30.1%) were significantly thicker at end diastole (P<0.01). Delayed enhancement correlated positively with perfusion defects (r=0.5, P<0.01) and hypokinetic segments (r=0.3, P<0.05).
Conclusion:
Delayed myocardial enhancement is most commonly found in hypertrophic segments but also can be seen in segments with normal wall thickness. Perfusion defects at rest and impaired contractile function are related abnormalities with delayed myocardial enhancement. Further studies are necessary to assess the role of myocardial tagging, first-pass perfusion, and delayed enhancement in risk stratification for patients with HCM.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Magnetic Resonance Imaging
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI

